Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial.

Messing EM, Tangen CM, Lerner SP, Sahasrabudhe DM, Koppie TM, Wood DP Jr, Mack PC, Svatek RS, Evans CP, Hafez KS, Culkin DJ, Brand TC, Karsh LI, Holzbeierlein JM, Wilson SS, Wu G, Plets M, Vogelzang NJ, Thompson IM Jr.

JAMA. 2018 May 8;319(18):1880-1888. doi: 10.1001/jama.2018.4657.

2.

Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study.

Kerns SL, Fung C, Monahan PO, Ardeshir-Rouhani-Fard S, Abu Zaid MI, Williams AM, Stump TE, Sesso HD, Feldman DR, Hamilton RJ, Vaughn DJ, Beard C, Huddart RA, Kim J, Kollmannsberger C, Sahasrabudhe DM, Cook R, Fossa SD, Einhorn LH, Travis LB; Platinum Study Group.

J Clin Oncol. 2018 May 20;36(15):1505-1512. doi: 10.1200/JCO.2017.77.0735. Epub 2018 Apr 4.

3.

TGFβ Superfamily Members Mediate Androgen Deprivation Therapy-Induced Obese Frailty in Male Mice.

Pan C, Singh S, Sahasrabudhe DM, Chakkalakal JV, Krolewski JJ, Nastiuk KL.

Endocrinology. 2016 Nov;157(11):4461-4472. Epub 2016 Sep 9.

4.

Targeted Therapy Based on Tumor Genomic Analyses in Metastatic Urachal Carcinoma.

Loh KP, Mondo E, Hansen EA, Sievert L, Fung C, Sahasrabudhe DM, Guancial E.

Clin Genitourin Cancer. 2016 Aug;14(4):e449-52. doi: 10.1016/j.clgc.2016.03.013. Epub 2016 Mar 24. No abstract available.

PMID:
27102403
5.

Reply to S. Alanee et al.

Fung C, Fossa SD, Milano MT, Sahasrabudhe DM, Peterson DR, Travis LB.

J Clin Oncol. 2016 Apr 10;34(11):1285-6. doi: 10.1200/JCO.2015.65.7015. Epub 2016 Feb 8. No abstract available.

PMID:
26858338
6.

Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study.

Fung C, Fossa SD, Milano MT, Sahasrabudhe DM, Peterson DR, Travis LB.

J Clin Oncol. 2015 Oct 1;33(28):3105-15. doi: 10.1200/JCO.2014.60.3654. Epub 2015 Aug 3.

7.

A case series of transformation of teratoma to primitive neuroectodermal tumor: evolving management of a rare malignancy.

Dunne RF, Sahasrabudhe DM, Messing EM, Jean-Gilles J, Fung C.

Rare Tumors. 2014 Mar 18;6(1):5268. doi: 10.4081/rt.2014.5268. eCollection 2014 Jan 23.

8.

Impact of bladder cancer on health related quality of life in 1,476 older Americans: a cross-sectional study.

Fung C, Pandya C, Guancial E, Noyes K, Sahasrabudhe DM, Messing EM, Mohile SG.

J Urol. 2014 Sep;192(3):690-5. doi: 10.1016/j.juro.2014.03.098. Epub 2014 Apr 1.

9.

An observational study of plasma vascular endothelial growth factors (VEGF) A and D expression in non-localized prostate cancer.

Verdoorn BP, Feng C, Ricke WA, Sahasrabudhe DM, Kilari D, Kohli M.

J Mens Health. 2012 Sep 1;9(3):182-189.

10.

Germline predictors of androgen deprivation therapy response in advanced prostate cancer.

Kohli M, Riska SM, Mahoney DW, Chai HS, Hillman DW, Rider DN, Costello BA, Qin R, Lamba J, Sahasrabudhe DM, Cerhan JR.

Mayo Clin Proc. 2012 Mar;87(3):240-6. doi: 10.1016/j.mayocp.2011.09.009.

11.

C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer.

Evans EE, Henn AD, Jonason A, Paris MJ, Schiffhauer LM, Borrello MA, Smith ES, Sahasrabudhe DM, Zauderer M.

Mol Cancer Ther. 2006 Nov;5(11):2919-30.

13.

The influence of host response on colorectal cancer prognosis.

Shunyakov L, Ryan CK, Sahasrabudhe DM, Khorana AA.

Clin Colorectal Cancer. 2004 May;4(1):38-45. Review.

PMID:
15207019
14.

Pilot study using gabapentin for tamoxifen-induced hot flashes in women with breast cancer.

Pandya KJ, Thummala AR, Griggs JJ, Rosenblatt JD, Sahasrabudhe DM, Guttuso TJ, Morrow GR, Roscoe JA.

Breast Cancer Res Treat. 2004 Jan;83(1):87-9.

PMID:
14997058
15.

A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma.

Khorana AA, Rosenblatt JD, Sahasrabudhe DM, Evans T, Ladrigan M, Marquis D, Rosell K, Whiteside T, Phillippe S, Acres B, Slos P, Squiban P, Ross M, Kendra K.

Cancer Gene Ther. 2003 Apr;10(4):251-9.

PMID:
12679797
17.

Lethality-based selection of recombinant genes in mammalian cells: application to identifying tumor antigens.

Smith ES, Mandokhot A, Evans EE, Mueller L, Borrello MA, Sahasrabudhe DM, Zauderer M.

Nat Med. 2001 Aug;7(8):967-72.

PMID:
11479631
18.

CD-20 expression in post-transplant lymphoproliferative disorders: treatment with rituximab.

Ifthikharuddin JJ, Mieles LA, Rosenblatt JD, Ryan CK, Sahasrabudhe DM.

Am J Hematol. 2000 Oct;65(2):171-3. Review.

19.

Active specific immunotherapy for metastatic colorectal carcinoma: phase I study of an allogeneic cell vaccine plus low-dose interleukin-1 alpha.

Woodlock TJ, Sahasrabudhe DM, Marquis DM, Greene D, Pandya KJ, McCune CS.

J Immunother. 1999 May;22(3):251-9.

PMID:
10335485
20.

Medical oncology and geriatric medicine: is it time for fellowship integration?

Bennett JM, Sahasrabudhe DM, Hall WJ.

Cancer. 1997 Oct 1;80(7):1351-3.

PMID:
9317190
21.

Effect of murine interferon alpha/beta on tumour-induced suppressor function.

Sahasrabudhe DM, Dusel JC.

Cancer Immunol Immunother. 1994 Dec;39(6):360-6.

PMID:
8001023
22.

Shared T cell-defined antigens on independently derived tumors.

Sahasrabudhe DM, Burstyn D, Dusel JC, Hibner BL, Collins JL, Zauderer M.

J Immunol. 1993 Dec 1;151(11):6302-10.

PMID:
8245469
23.

Paraneoplastic Raynaud's phenomenon.

DeCross AJ, Sahasrabudhe DM.

Am J Med. 1992 May;92(5):571-2. No abstract available.

PMID:
1580306
24.

Suppression of delayed type hypersensitivity by desferoxamine.

Sahasrabudhe DM, Dusel J, Jedlika S.

J Immunother (1991). 1991 Apr;10(2):112-9.

PMID:
2043591
25.

Renal cell carcinoma treated by vaccines for active specific immunotherapy: correlation of survival with skin testing by autologous tumor cells.

McCune CS, O'Donnell RW, Marquis DM, Sahasrabudhe DM.

Cancer Immunol Immunother. 1990;32(1):62-6.

PMID:
2289200
26.

Inhibition of suppressor T lymphocytes by murine interferon beta.

Sahasrabudhe DM.

J Exp Med. 1987 Nov 1;166(5):1573-8.

27.

Inhibition of suppressor T lymphocytes (Ts) by cimetidine.

Sahasrabudhe DM, McCune CS, O'Donnell RW, Henshaw EC.

J Immunol. 1987 May 1;138(9):2760-3.

PMID:
2952721
28.

Specific immunotherapy with suppressor function inhibition for metastatic renal cell carcinoma.

Sahasrabudhe DM, deKernion JB, Pontes JE, Ryan DM, O'Donnell RW, Marquis DM, Mudholkar GS, McCune CS.

J Biol Response Mod. 1986 Dec;5(6):581-94.

PMID:
3491881
29.

Decreasing M spike with increasing tumor burden in multiple myeloma.

Sahasrabudhe DM, Parker JC.

Arch Intern Med. 1981 Aug;141(9):1152-3. No abstract available.

PMID:
7259374

Supplemental Content

Loading ...
Support Center